Funding
← Back to your selection

Qumra Capital

Activity from announced rounds

Activity in this selectionHealthtech

Qumra Capital is the investment firm identified by Remepy and in Buildots’ issuer financing announcement.

Recorded funding activity

Buildots measures construction progress from site imagery. Remepy combines medicines with therapeutic applications, while QuantHealth simulates trials before enrollment. The recorded activity does not assign a particular unnamed fund.

Sources
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$81M
2 disclosed · full round size, not this investor’s share

By stage

Growth1
Series A1
Series B1

By primary sector

Biotech2
Healthtech1

By country

Israel2
United States1

Rounds

3 in this selection
Remepy

Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps

$36MSeries A
Role not disclosed
QuantHealth

AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment

$45MSeries B
Role not disclosed
TytoCare

AI-first clinical enablement company and developer of remote physical examination technology featuring FDA-cleared medical devices

>$25MGrowth
Role not disclosed